Chae et al., 2023 - Google Patents
3D bioprinting strategy for engineering vascularized tissue modelsChae et al., 2023
View HTML- Document ID
- 13793346748699792652
- Author
- Chae S
- Ha D
- Lee H
- Publication year
- Publication venue
- International Journal of Bioprinting
External Links
Snippet
ABSTRACT Leveraging three-dimensional (3D) bioprinting in the fields of tissue engineering and regenerative medicine has rapidly accelerated progress toward the development of living tissue constructs and biomedical devices. Ongoing vigorous research …
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/14—Scaffolds; Matrices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chae et al. | 3D bioprinting strategy for engineering vascularized tissue models | |
Sasmal et al. | 3D bioprinting for modelling vasculature | |
Ma et al. | Bioprinting of 3D tissues/organs combined with microfluidics | |
Ren et al. | Developments and opportunities for 3D bioprinted organoids | |
Vera et al. | Engineering tissue barrier models on hydrogel microfluidic platforms | |
Qasim et al. | 3D printing approaches for cardiac tissue engineering and role of immune modulation in tissue regeneration | |
Memic et al. | Bioprinting technologies for disease modeling | |
Borovjagin et al. | From microscale devices to 3D printing: advances in fabrication of 3D cardiovascular tissues | |
Hwang et al. | 3D bioprinting-based vascularized tissue models mimicking tissue-specific architecture and pathophysiology for in vitro studies | |
Serpooshan et al. | Bioengineering cardiac constructs using 3D printing | |
Miller | The billion cell construct: will three-dimensional printing get us there? | |
Satpathy et al. | Developments with 3D bioprinting for novel drug discovery | |
Jafarkhani et al. | Bioprinting in vascularization strategies | |
Thayer et al. | History and trends of 3D bioprinting | |
Fransen et al. | Bioprinting of kidney in vitro models: cells, biomaterials, and manufacturing techniques | |
Lin et al. | Modeling organ-specific vasculature with organ-on-a-chip devices | |
Li et al. | Improving bioprinted volumetric tumor microenvironments in vitro | |
Tabatabaei Rezaei et al. | Recent advances in organ‐on‐chips integrated with bioprinting technologies for drug screening | |
Kim et al. | Bioprinting methods for fabricating in vitro tubular blood vessel models | |
Wang et al. | Advances in human organoids-on-chips in biomedical research | |
Lee et al. | Gaining new biological and therapeutic applications into the liver with 3D in vitro liver models | |
Ke et al. | Evolution of 3D bioprinting-from the perspectives of bioprinting companies | |
WO2019237061A1 (en) | A 3d bioprinted perfusable platform for high-throughput disease modeling and drug screening | |
Khanna et al. | Cardiovascular human organ‐on‐a‐chip platform for disease modeling, drug development, and personalized therapy | |
Lin et al. | 3D bioprinting for tumor metastasis research |